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Antiviral RNA Silencing Initiated in the Absence of RDE-4, a Double-
Stranded RNA Binding Protein, in Caenorhabditis elegans
Xunyang Guo, Rui Zhang, Jeffrey Wang, Rui Lu
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA
Small interfering RNAs (siRNAs) processed from double-stranded RNA (dsRNA) of virus origins mediate potent antiviral de-
fense through a process referred to as RNA interference (RNAi) or RNA silencing in diverse organisms. In the simple inverte-
brate Caenorhabditis elegans, the RNAi process is initiated by a single Dicer, which partners with the dsRNA binding protein
RDE-4 to process dsRNA into viral siRNAs (viRNAs). Notably, in C. elegans this RNA-directed viral immunity (RDVI) also re-
quires a number of worm-specific genes for its full antiviral potential. One such gene is rsd-2 (RNAi spreading defective 2), which
was implicated in RDVI in our previous studies. In the current study, we first established an antiviral role by showing that rsd-2
null mutants permitted higher levels of viral RNA accumulation, and that this enhanced viral susceptibility was reversed by ecto-
pic expression of RSD-2. We then examined the relationship of rsd-2 with other known components of RNAi pathways and es-
tablished that rsd-2 functions in a novel pathway that is independent of rde-4 but likely requires the RNA-dependent RNA poly-
merase RRF-1, suggesting a critical role for RSD-2 in secondary viRNA biogenesis, likely through coordinated action with RRF-1.
Together, these results suggest that RDVI in the single-Dicer organism C. elegans depends on the collective actions of both RDE-
4-dependent and RDE-4-independent mechanisms to produce RNAi-inducing viRNAs. Our study reveals, for the first time, a
novel siRNA-producing mechanism in C. elegans that bypasses the need for a dsRNA-binding protein.
In fungi, plants, insects, and nematodes, double-stranded RNAs(dsRNAs), formed by complementary viral transcripts or
through intramolecular base pairing, trigger potent antiviral de-
fense through a process often referred to as RNA interference
(RNAi) (1). Increasing evidence suggested that this RNA-directed
viral immunity (RDVI) is initiated upon the processing of viral
dsRNA into small interfering RNAs (siRNAs) by an RNase III-like
enzyme called Dicer (2). Subsequently, these virus-derived
siRNAs are incorporated into RNA-induced silencing complexes
(RISCs), formed by Argonaute protein and cofactors, and serve as
sequence guides for target viral transcript selection and destruc-
tion (1). In diverse organisms, dsRNA binding proteins are essen-
tial components of RDVI that contribute to the biogenesis or
function of virus-derived siRNAs (viRNAs) (3–8). In plants,
RDVI is further potentiated by secondary viRNAs processed from
dsRNAs converted from cleaved viral transcripts by RNA-depen-
dent RNA polymerases (RdRPs) (9–12). Plant RDVI also involves
an intercellular signal that is believed to restrict systemic spread-
ing of the invading virus by priming an antiviral status prior to
virus arrival (13, 14). Recently, siRNAs were found to serve as the
physical carrier of this mobile silencing signal in plants (15, 16). In
the fruit fly RDVI also spreads systemically, although the mecha-
nism involved is different (17).
Since RNAi triggered by artificial dsRNA mechanistically reca-
pitulates RDVI, previous studies on artificial dsRNA-triggered
RNAi in C. elegans have significantly improved our understanding
of RDVI in nematode worms. Current models envision that the
worm RDVI is initiated upon the processing of viral dsRNA into
primary viRNAs by the worm Dicer, called DCR-1 (4, 5, 18).
DCR-1 also processes precursor microRNAs (miRNAs) into ma-
ture miRNAs, a class of endogenous small RNAs with important
roles in development (19). Whereas efficient processing of viral
dsRNA into primary viRNA requires a dsRNA binding protein,
termed RDE-4 (RNAi defective 4), the processing of precursor
miRNAs into mature miRNAs appears to be RDE-4 independent
(3, 5, 19–21). Interestingly, RDE-4, a key factor of RDVI, is also
conserved in the fruit fly, whose genome is known to encode two
Dicer proteins with dedicated function in the biogenesis of siRNA
and miRNA, respectively (7, 20–23). So far, at least two closely
related AGO proteins, RDE-1 (RNAi defective 1) and C04F12.1,
have been found to play an important role in RDVI in C. elegans
(3–5, 24). RDE-1 has the slicer activity that is required for the
maturation of RISC but not the cleavage of the target transcript
(25). Currently, how C04F12.1 contributes to RDVI remains
largely unknown. Efficient RDVI in C. elegans also requires an
RdRP, termed RRF-1, which produces 22-nucleotide (nt) single-
stranded secondary siRNAs in a Dicer-independent manner (4, 5,
26, 27) (28). The fact that RDE-1 is required for production of
secondary siRNAs suggests that RRF-1 functions downstream of
RDE-1 in the same genetic pathway (28, 29).
In addition to Dicer, AGO, and RdRP proteins, the worm
RDVI also requires some unique components, such as DRH-1
(Dicer-related RNA helicase 1) and RSD-2 (RNAi spreading de-
fective 2) (5). DRH-1 encodes a putative DEAD box RNA helicase
that shares significant sequence homology with RIG-I (retinoic
acid-inducible gene 1), a cytosolic virus sensor that initiates inter-
feron-mediated viral immunity upon virus detection in mammals
(30). Intriguingly, although essential to RDVI, DRH-1 appears to
be dispensable in RNAi triggered by artificial dsRNAs, suggesting
a dedicated role of DRH-1 in antiviral defense (5). Previously, we
reported that viRNAs detected in drh-1 mutants became undetect-
able in drh-1;rde-4 double mutants (5), suggesting that DRH-1,
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together with RDE-1 and RRF-1, functions in the same genetic
pathway as RDE-4.
RSD-2, together with SID-1 (systemic RNA interference defi-
cient 1), was originally identified as one of the key factors that
enable systemic spreading of RNAi (31–33). A recent study sug-
gested that RSD-2 contributes to the accumulation of secondary
siRNAs in both exogenous and endogenous RNAi pathways (34).
Since rsd-2 mutants displayed defects in transposon silencing un-
der unfavorable conditions, it is believed that RSD-2 plays an im-
portant role in maintaining chromosome integrity (35). SID-1
contains multiple putative transmembrane domains and has been
shown to be required for dsRNA intake (33, 36, 37). Interestingly,
a recent study suggested that at least two classes of silencing
dsRNAs that move between C. elegans tissues can act as or generate
the systemic silencing signal (38). Currently, whether SID-1 con-
tributes to systemic RNAi by transporting these two classes of
silencing RNAs remains largely unknown.
Previously, high concentrations of dsRNAs were found to trig-
ger efficient RNAi in the absence of RDE-4 (39). Currently, the
biological significance of this observation remains largely un-
known. By analyzing viral replication and viRNA accumulation in
worm single and double mutants defective in rsd-2, we show here
that RSD-2, as an important component of worm RDVI, func-
tions downstream of primary viRNA biogenesis. Most impor-
tantly, with an increase in viral replication, primary viRNAs accu-
mulated to a higher level in rsd-2;rde-4 double mutants than in
rsd-2 single mutants, suggesting an rde-4-independent mecha-
nism for the biogenesis of primary viRNAs in C. elegans. We fur-
ther showed that RRF-1, together with RDE-1, also contributed to
the rde-4-indepedent RDVI. Notably, although playing an essen-
tial role in facilitating the spreading of RNAi triggered by artificial
dsRNAs, SID-1 appears dispensable in RDVI targeting a natural
viral pathogen of C. elegans.
MATERIALS AND METHODS
Worm genetics. The Bristol isolate of C. elegans, N2, was used as the
reference strain in this study. All other strains used in this study are de-
rived from N2 and include drh-1 (tm1329), drh-2 (ok951), rde-1 (ne300),
rde-4 (ne337), rsd-2 (tm1429 and pk3307), sid-1 (qt2), and rrf-1 (pk1417)
mutants. The genotypes of drh-1, drh-2, rsd-2, and rrf-1 mutants were
confirmed using PCR. The primers used to confirm tm1329 and drh-2
alleles were described previously (5). The primer pairs used to confirm the
alleles are tm1429intf (CTACTAAACCGGTTACGTGT) and tm1429intb
(CCACAGGGATTTTGTAGGGA) for tm1429 and 1417EcoRV (AGGAG
AGCATAGAAGGATATCA) and 1417PfoI (GTCACGGGGAGCTATTG
TGAA) for pk1417. The genotypes of rde-1, sid-1, and rde-4 mutants were
confirmed using skn-1 feeding RNAi combined with genomic DNA se-
quencing. NGM plates seeded with Escherichia coli strain OP50 were used
to maintain all worm strains. Single and double mutants containing var-
ious transgenes were created through standard genetic crosses.
Plasmid constructs and transgenic worms. The construction of
FR1gfp replicon was described previously (5). Psur5::RSD-2 was devel-
oped by inserting RSD-2 coding sequence, amplified through reverse
transcription-PCR (RT-PCR), into the LR50 vector described previously
(40). The RSD-2 coding sequence in the resulting construct was con-
firmed by DNA sequencing. The plasmid construct used to drive gfp
dsRNA expression in E. coli was described previously (40). The chromo-
somal integrant for Psur5::RSD-2 was generated using a protocol de-
scribed previously (40).
RSD-2 function rescue assay. The RSD-2 function rescue assay uti-
lized ectopic expression of RSD-2 coding sequence in rsd-2 null mutants
(tm1429) carrying a nuclear transgene corresponding to the FR1gfp rep-
licon. The sur-5 promoter, known to be active in most of the worm cells
(41), was used to drive the expression of RSD-2. A construct that directs
mCherry expression in the pharynx tissue was used to produce a visual
mark for the Psur5::RSD-2 transgene. The RSD-2 function rescue assay
began with microinjection of Psur5::RSD-2 construct into the gonad of
rsd-2;FR1gfp worms together with the mCherry reporter construct. Be-
cause of the nature of worm transformation through gonad injection,
most of the transgenic extrachromosomal arrays are randomly passed on
to the next generations. As a result, some progenies are free of the extra-
chromosomal arrays and can serve as internal negative control. Upon heat
induction, which will initiate the replication of the FR1gfp replicon, trans-
genic worms marked with red fluorescence in the head will show no or
decreased green fluorescence if the Psur5::RSD-2 transgene is able to re-
store the function of RSD-2 in the rsd-2 mutants.
RNA preparation and Northern analysis. Total RNA was prepared 48
h after heat induction using TRI reagent by following the manufacturer’s
instructions (Sigma-Aldrich, Inc.). Small RNA species in the total RNA
samples were further enriched using the mirVana kit (Ambion). For the
detection of high-molecular-weight viral RNAs, 4 g total RNA of each
sample was fractionated in 1.2% agarose gel. For the detection of small
RNA, including viRNAs and miRNAs, 10 to 20 g of small RNA per
sample was resolved in 15% acrylamide denaturing gel. After electropho-
resis, all RNA samples were transferred onto a Hybond N membrane
(GE Healthcare Inc.) and UV cross-linked using 1.8  105 J/cm2 as the
output power (SpectroLinker).
The blots for the detection of high-molecular-weight viral RNAs were
hybridized with alkaline phosphatase-labeled cDNA probes prepared us-
ing an AlkPhos direct labeling module (GE Healthcare). The probes for
FR1gfp transcript detection were prepared using cDNA fragments ampli-
fied from the green fluorescent protein (GFP) coding sequence within
FR1gfp. The probes used to detect Orsay virus RNA1 were prepared using
cDNA fragments amplified, through RT-PCR, from the 3= end of Orsay
virus RNA1 genome. The hybridization was performed at 65°C overnight.
After washing at 65°C three times, the labeled cDNA probes were detected
using CDP-Star detection reagent by following the manufacturer’s in-
structions (GE Healthcare).
The detection of siRNAs and miRNAs adopted a protocol described
previously (40). For the detection of FR1gfp-derived siRNAs, DNA oligo-
nucleotides covering the entire subgenomic RNA sequence were labeled
using the digoxigenin (DIG) oligonucleotide tailing kit (Roche Applied
Science). DNA oligonucleotides with the sequence ATTGCCGTACTGA
ACGATCTCA were labeled and used for the detection of miR-58. Four
DNA oligonucleotides with sizes of 19, 21, 23, and 25 nt, respectively, were
detected using DIG-labeled DNA oligonucleotides and, together with
miR-58, served as size references.
Infectious filtrate preparation and Orsay virus inoculation. Orsay
virus was maintained using the JU1580 isolate of C. elegans at room tem-
perature by following a protocol described previously (6). To prepare
Orsay virus inoculum, JU1580 worms infected with Orsay virus were
washed off, using M9 buffer, from slightly starved 10-cm agar plates. After
spinning at low speed, the virus-containing supernatant was filtered
through a 0.22-m filter unit (Millipore), and the filtrate was used to
resuspend pelleted OP50 E. coli for NGM plate seeding.
RNAi experiments. Feeding RNAi targeting the endogenous gene
skin-1 or the transgene gfp was performed using a bacterial feeding pro-
tocol described previously (42). NGM agar plates containing 5 mM iso-
propyl--D-thiogalactopyranoside (IPTG) and 50 mg/ml carbenicillin
were used to prepare the feeding RNAi food. All feeding RNAi experi-
ments were carried out at room temperature.
Imaging microscopy. The green and red fluorescence images were
recorded using the same exposure for each set of images. A Nikon digital
camera p7000 mounted on a Nikon SMZ1500 microscope was used to
record all images.
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rsd-2 is not essential for the biogenesis of primary viRNAs. rsd-2
of C. elegans was first implicated in RDVI through an RNAi screen
that selected for genes whose downregulation by dsRNA feeding
led to loss of RDVI (5). To confirm that the loss of RDVI in worms
fed with rsd-2-targeting dsRNA was indeed caused by partial loss
of rsd-2 function, we examined the replication of FR1gfp replicon
in the mutant worms containing the tm1429 or pk3307 allele of
rsd-2. The tm1429 allele contains a 251-nt deletion, spanning from
nt 1376 to 1626 of rsd-2 cDNA, and is predicted to produce a
truncated RSD-2 that contains only the first 458 amino acid (aa)
residues of the 1,266-aa wild-type RSD-2. Conversely, the pk3307
allele contains a premature stop codon in the RSD-2 coding se-
quence that caused the truncation of the last 542 aa of RSD-2.
Thus, both rsd-2 alleles are considered null alleles. The FR1gfp
replicon was developed from flock house virus (FHV) RNA1 by
replacing the coding sequence of B2, the FHV-encoded RNAi sup-
pressor, with that of green fluorescence protein (GFP). As a result,
the replication of FR1gfp is subdued by RDVI in wild-type N2
worms but rescued in RDVI-defective worms, such as the rde-1
mutants. As shown in Fig. 1A, similar to the rde-1 mutants, both
rsd-2 mutants supported elevated accumulation of FHV RNAs
(Fig. 1A, compare lanes 3 and 4 to lanes 1 and 2), confirming a
critical role of wild-type RSD-2 in FHV-targeting RDVI. En-
hanced accumulation was also observed in the rsd-2 mutants for
Orsay virus, a natural viral pathogen of C. elegans that is closely
related to FHV (Fig. 1B, compare lanes 2 and 3 to lane 1) (6). These
results together strongly suggested that RSD-2 plays an important
role in RDVI.
To reconfirm that the loss of RDVI in rsd-2 mutants indeed
resulted from the rsd-2 null alleles but not any other closely linked
genetic alleles, we checked if ectopic expression of wild-type
RSD-2 restores RDVI in rsd-2 mutants (tm1429) containing the
FR1gfp replicon. The ectopic expression of wild-type RSD-2 cod-
ing sequence was achieved through gonad microinjection of plas-
mid construct containing RSD-2 coding sequence driven by the
sur-5 promoter (Fig. 1C) (41). A plasmid construct that directs
mCherry expression in pharynx tissue was coinjected to produce a
visual reporter for the transgene. As shown in Fig. 1C, FR1gfp
replication, manifested as green fluorescence, was suppressed in
rsd-2 mutants containing the Psur-5::RSD-2 transgene (compare
the worms that showed red fluorescence in the heads to worms
that did not). Consistent with this observation, FR1gfp transcripts
were detected at a reduced level in worms containing the Psur-5::
RSD-2 transgene (Fig. 1D, compare lane 2 to lane 3). These results
confirmed that RSD-2 indeed plays an important role in worm
RDVI.
rsd-2 is known to contribute to the accumulation of secondary,
but not primary, endogenous siRNAs (34). To find out whether
RSD-2 contributes to RDVI through a similar mechanism, we
checked the accumulation of viRNAs in rsd-2 mutants (tm1429)
using Northern blotting. Both rde-1 and rde-4 play essential roles
in worm RDVI. However, virus-derived siRNAs accumulate to
readily detectable levels in rde-1 but not rde-4 mutants (3, 5).
Thus, as a control, the accumulation of viRNAs in rde-1 and rde-4
mutants was also detected in this test. As shown in Fig. 1E, al-
though not detectable in wild-type N2 worms or rde-4 mutants,
FR1gfp-derived viRNAs were detected at high levels in rde-1 mu-
tants, with a major band detected at the position corresponding to
23 nt. FR1gfp-derived siRNAs were also detected in rsd-2 mutants
with a pattern similar to that in rde-1 mutants but at a visibly lower
level. Previously, it has been shown that primary siRNAs pro-
duced by worm Dicer are predominantly 23 nt in size and accu-
mulate at high levels in rde-1 mutants (18, 29, 43, 44). This result
suggested that rsd-2 is not essential for the biogenesis of primary
viRNAs.
rsd-2 contributes to rde-4-independent antiviral silencing.
We previously reported that FR1gfp-derived siRNAs detected in
drh-1 mutants become undetectable in drh-1;rde-4 double mu-
tants, suggesting that drh-1 and rde-4 function in a linear genetic
pathway (5). To find out whether rsd-2 also functions in the same
genetic pathway, we compared the accumulation of primary
viRNAs in double mutants corresponding to drh-1;rde-4, rsd-2;
rde-4, and rsd-2;drh-1. As shown in Fig. 2A, although not detect-
able in drh-1;rde-4 double mutants, FR1gfp-derived primary
siRNAs were detected in both rsd-2;drh-1 and rsd-2;rde-4 double
mutants (compare lane 3 to lanes 1 and 4). Most importantly, an
enhanced replication for both Orsay virus and FR1gfp was ob-
served in rsd-2;rde-4 and rsd-2;drh-1 double mutants compared to
rde-4 and drh-1 single mutants, respectively (Fig. 2B and C, left).
These observations together suggested an rde-4-independent
mechanism that directs antiviral silencing in an rsd-2-dependent
manner in C. elegans. RDE-1 specifically recruits primary siRNAs,
but not secondary siRNAs, for target RNA selection and is be-
lieved to function downstream of RDE-4 (29). Thus, we expected
to see enhanced viral replication in rsd-2;rde-1 double mutants
compared to rde-1 single mutants if rsd-2 indeed contributes to
RDVI in an rde-4-independent manner. As shown in Fig. 2B and
C, right, enhanced viral replication was observed, although to a
lesser extent, in rsd-2;rde-1 double mutants compared to rde-1
single mutants. As expected, FR1gfp-derived siRNAs accumulated
in rsd-2;rde-1 double mutants (Fig. 2A, lane 2). Taken together,
these results strongly suggest that there is an rde-4-independent
but rsd-2-dependent pathway contributing to RDVI in C. elegans.
rsd-2 and rrf-1 function in the same RDVI pathways. rrf-1
encodes an RdRP that initiates de novo synthesis of secondary
siRNAs using the targeted transcript as the template in RNAi (26,
27, 45, 46). To find out whether rsd-2 functions in the same genetic
pathway as rrf-1, which is known to function downstream of rde-4
and rde-1 (28, 29), we checked viral replication in rsd-2;rrf-1 dou-
ble mutants compared to the single mutants. We expected to see
enhanced viral replication in the double mutants if rsd-2 and rrf-1
function in separate genetic pathways. However, as shown in Fig.
3A, an enhancement in the replication of FR1gfp or Orsay virus
was not observed in the double mutants compared to the single
mutants (compare lane 4 to lanes 2 and 3 in the left panel and lane
5 to lanes 3 and 4 in the right panel). Consistently, FR1gfp-derived
23-nt primary siRNAs accumulated to comparable levels in the
rsd-2;rrf-1 double mutants and in the single mutants (Fig. 3B,
compare lanes 1 and 2 to lane 7). This result, together with the
results shown in Fig. 2, suggest that both rrf-1 and rsd-2 function
in two independent genetic pathways that mediate rde-4-depen-
dent and rde-4-independent antiviral silencing, respectively.
rrf-1 contributes to rde-4-independent antiviral silencing.
To confirm that rrf-1 indeed contributes to rde-4-independent
RDVI, we first compared the replication of both FR1gfp and Orsay
virus in rrf-1;rde-4 and rrf-1;drh-1 double mutants to that in the
single mutants corresponding to rrf-1, drh-1, and rde-4. We ex-
pected to see enhanced viral replication in the double mutants if
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FIG 1 rsd-2 is not essential for the biogenesis of primary viRNA. (A) Northern blot showing the accumulation of FR1gfp genomic and subgenomic transcripts in
different genetic backgrounds. Total RNA was extracted from heat-induced worms 48 h after heat induction. The viral transcripts were detected using probes prepared
from full-length gfp cDNA. RNA1, genomic RNA of FR1gfp; RNA3, subgenomic RNA of FR1gfp; rRNA, methylene blue-stained rRNA serving as an equal loading
control. (B) Accumulation of Orsay virus RNA1 (ovRNA1) in wild-type N2 worms and rsd-2 mutants carrying the tm1429 or NL3307 allele as indicated. Total RNA was
prepared 72 h after viral inoculation. Orsay virus RNA1 was detected using cDNA probes prepared using a cDNA fragment amplified from the 3= end of Orsay virus
RNA1. (C) The upper panel shows the structure of Psur-5::rsd-2. Psur-5, the promoter for the endogenous gene sur-5; RSD-2, the coding sequence of wild-type rsd-2;
UTR, the 3=-end untranslated region of unc-54. The lower panel shows visualization of green fluorescence in rsd-2 mutants (tm1429 allele) carrying the FR1gfp replicon
transgene and extrachromosmal array corresponding to Psur-5::RSD-2 48 h after heat induction. Shown here are merged images recorded, using the same exposure,
under red fluorescence and green fluorescence. Worms showing red color are transgenic for Psur-5::RSD-2. (D) Accumulation of FR1gfp transcripts in wild-type N2
worms, drh-1 mutants, and rsd-2 mutants (tm1429) with or without the extrachromosomal assay derived from the Psur-5::RSD-2 construct. RSD-2wt denotes the
Psur-5::RSD-2 transgenic array. (E) Accumulation of FR1gfp-derived siRNAs in wild-type N2 worms and RDVI-defective mutants as indicated. Lane M, four DNA
oligonucleotides with sizes of 19, 21, 23, and 25 nt detected and used, together with miR-58, as size references.
Guo et al.



























































rrf-1 indeed contributes to rde-4-independent RDVI. As shown in
Fig. 4A and B, both FR1gfp and Orsay virus replicated to higher
levels in the double mutants than in the single mutants. Most
importantly, we detected FR1gfp-derived primary siRNAs in the
rrf-1;rde-4 and rrf-1;drh-1 double mutants, in contrast to what was
seen in drh-1;rde-4 double mutants (Fig. 4C, compare lanes 2 and
4 to lane 1). As shown in Fig. 4A and B, an increase in FR1gfp
replication was observed in the rrf-1;rde-1 double mutants com-
pared to the single mutants, although such an increase was not
clear for Orsay virus. As expected, FR1gfp-derived primary
siRNAs also accumulated in rde-1;rrf-1 double mutants (Fig. 4C,
lane 3). These observations confirmed that rrf-1 plays a role in
rde-4-independnet RDVI.
rde-1 plays a role in rde-4-independent RDVI. Previously, en-
hanced viral replication was observed in drh-1;rde-1, but not in
drh-1;rde-4, double mutants compared to the single mutants (5),
suggesting a role for rde-1 in rde-4-independent RDVI. To find
out whether rde-1 indeed contributes to rde-4-independent
RDVI, we compared both viral replication and primary viRNA
accumulation in rde-1;rde-4 double mutants and the single mu-
tants. We expected to see enhanced viral replication and accumu-
lation of primary viRNAs if rde-1 indeed plays a role in rde-4-
independent RDVI. As shown in Fig. 5A, both Orsay virus and
FR1gfp replicated to higher levels in the double mutants than the
single mutants. Most importantly, FR1gfp-derived primary
siRNAs, although not detectable in the drh-1;rde-4 double mu-
tants, were readily detected in rde-1;rde-4 double mutants (Fig.
5B, compare lane 3 to lane 2). These results together suggested that
rde-1 also plays a role in rde-4-independent RDVI.
sid-1 is not required for RDVI targeting Orsay virus. In C.
elegans, RNAi triggered by artificial long dsRNA spreads systemi-
cally and causes sequence-specific silencing in distant tissues that
are not exposed to the dsRNA trigger (32). This observation raised
the question of whether, like that in plants (13, 14), worm RDVI
involves an intercellular signal that prevents viruses from spread-
ing systemically. Previously, we have shown that RDVI triggered
by an FHV replicon was not compromised in sid-1 mutants (40)
defective in RNAi spreading (33, 36, 47). However, since potent
RDVI will have been triggered in every individual cell that con-
tains the replicon transgene, a systemic silencing signal may not be
needed to silence such a viral replicon that is not known to move
systemically. To find out whether worm RDVI indeed spreads
systemically to restrict virus spread under natural conditions, we
compared Orsay virus infection between wild-type N2 worms and
worms defective in sid-1. As shown in Fig. 6, an increase in Orsay
virus replication was not detected in sid-1 mutants compared to
that in wild-type N2 worms (compare lane 4 to lane 2). Based on
FIG 2 rsd-2 contributes to rde-4-independent antiviral silencing. (A) Accu-
mulation of FR1gfp-derived siRNAs in double mutants defective in RDVI.
Experimental details are the same as those described in the legend to Fig. 1E.
(B) Accumulation of Orsay virus RNA1 (ovRNA1) in wild-type N2 worms and
RDVI-defective mutants carrying single or double mutations as indicated. See
the legend to Fig. 1B for experimental details. (C) Accumulation of FR1gfp
transcripts in various genetic backgrounds as indicated. See the legend to Fig.
1A for experimental details.
FIG 3 rsd-2 and rrf-1 function in the same antiviral silencing pathways. (A)
Accumulation of FR1gfp and Orsay virus transcripts in various genetic back-
grounds as indicated. See the legend to Fig. 1A for experimental details. (B)
The accumulation of FR1gfp-derived siRNAs in single or double mutants con-
taining rsd-2 and/or rrf-1 null alleles. See the legend to Fig. 1E for experimental
details.
RDE-4-Independent Antiviral Silencing



























































this observation, we concluded that sid-1-mediated systemic
RNAi is not required for restricting Orsay virus infection in C.
elegans.
DISCUSSION
rsd-2 was first identified as a gene that enables RNAi spreading
from soma to germ line (31). A role of rsd-2 in RDVI was then
revealed in a genetic screening that utilized RNAi-mediated gene
knockdown to phenocopy genetic mutants (5). Recently, a genetic
study further suggested that rsd-2 helps maintain normal chromo-
somal function, such as transposon control, under unfavorable
conditions (35). Currently, how rsd-2 contributes to those biolog-
ical processes remains poorly understood. rsd-2 is unique to nem-
atode worms, such as C. elegans, which are known to encode the
single Dicer required for the biogenesis of both siRNAs and
miRNAs. Thus, the functional and mechanistic study of rsd-2 is
expected not only to shed light on the mechanism by which rsd-2
helps maintain chromosomal integrity in response to environ-
mental stresses but also to reveal the uniqueness of RDVI in single-
Dicer invertebrates. Here, we show that rsd-2 functions in two
parallel genetic pathways that mediate antiviral silencing in rde-4-
dependent and rde-4-independent manners. In Arabidopsis,
dsRNA binding protein regulates RDVI by facilitating the process-
ing of viral dsRNA into siRNAs by one of the four Dicers (8, 48). In
Drosophila, the RDE-4 homologue R2D2 contributes to the func-
tion of viRNAs produced by one of the two drosophila Dicers (7,
22, 49). Therefore, by demonstrating the rde-4-indpendent mech-
anism for primary viRNA biogenesis, our study, for the first time,
suggested that RDVI in single-Dicer invertebrates can be initiated
in the absence of a dsRNA binding protein.
Previously, it has been shown that dsRNA of high concentra-
tion triggers RNAi in C. elegans in the absence of RDE-4 (39). This
observation suggests that viruses, as powerful replicators that rap-
idly produce large amounts of dsRNA replication intermediates,
trigger RDVI in the absence of RDE-4. Here, we show that with an
increase in viral replication level, primary viRNAs were detected at
high levels in rde-4 mutants containing either rsd-2 or the rrf-1
null allele, suggesting an rde-4-independent mechanism for the
FIG 4 rrf-1 contributes to rde-4-independent antiviral silencing. (A) Accu-
mulation of Orsay virus RNA1 (ovRNA1) in wild-type N2 worms and RDVI-
defective mutants carrying single or double mutations as indicated. (B) Accu-
mulation of FR1gfp transcripts in wild-type N2 worms and RDVI-defective
mutants carrying single or double mutations as indicated. (C) Accumulation
of FR1gfp-derived siRNAs in double mutants, as indicated, defective in RDVI.
FIG 5 rde-1 contributes to rde-4-independent antiviral silencing. (A) Viral
replication is further enhanced in rde-1;rde-4 double mutants compared to the
single mutants. Shown here is the accumulation of Orsay virus (left panel) and
FR1gfp transcripts in single or double mutants containing rde-1 and/or rde-4
null alleles. (B) Accumulation of FR1gfp-derived primary siRNAs in single or
double mutants containing rde-1 and/or rde-4 null alleles.
FIG 6 sid-1 is not required for RDVI in C. elegans. Shown is the accumulation
of Orsay virus RNA1 in wild-type N2 worms and sid-1 mutants. See the legend
to Fig. 1B for experimental details.
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generation of primary viRNAs (Fig. 2 and 4). Apparently such an
increase in viral replication and viRNA accumulation cannot be
attributed to residual rde-4 function in the rde-4 allele used in this
study, since FR1gfp-derived siRNAs were not detected in rde-4
single or drh-1;rde-4 double mutants under the same conditions
(5) (Fig. 1E, 2A, 4C, and 5B). Thus, by demonstrating the exis-
tence of an rde-4-independent pathway for antiviral silencing, we
explained why dsRNAs of high levels triggers RNAi in the absence
of RDE-4 in C. elegans (39). Notably, although readily detectable
in worms, such as rde-1, rrf-1, and rsd-2 mutants, that are defective
in secondary viRNA biogenesis, virus-derived primary siRNAs
were hardly detectable in wild-type N2 worms or worms defective
in rde-4 (Fig. 1E, 2A, 3C, and 4C). This may simply reflect the fact
that antiviral silencing in both rde-4-dependent and rde-4-inde-
pendent mechanisms is amplified by the secondary viRNAs and,
as a result, much less viral dsRNA will be processed into primary
viRNAs by Dicer in the presence of secondary viRNAs.
Notably, our observations suggested that rde-1 also plays a role
in rde-4-independent RDVI similar to that of rsd-2 (Fig. 5). Inter-
estingly, an increase in FHV replication level was observed in rde-
1;rsd-2 double mutants compared to rde-1 single mutants. rde-1
probably plays a major role in rde-4-dependent RDVI but a minor
role in rde-4-independent RDVI, and as a result, antiviral silencing
in rde-1 mutants is further compromised in the presence of an
rsd-2 null allele. Nevertheless, by analyzing the accumulation of
viral transcripts and primary viRNAs in various worm single and
double mutants defective in RDVI, our study demonstrated, for
the first time, that in addition to the conventional rde-4-depen-
dent pathway, there is an rde-4-independent pathway for antiviral
silencing in C. elegans (Fig. 7). Previously, we showed that another
RDE-1-related worm AGO, termed C04F12.1, plays a role in
RDVI. It would be interesting to test whether C04F12.1 plays a
role in rde-4-independent RDVI. C. elegans is known to encode a
large number of AGO proteins. Thus, testing the rde-4 depen-
dence of C04F12.1 may allow us to address the question of
whether different worm AGO proteins specifically function in
mechanistically distinct RDVI pathways in C. elegans.
rsd-2 is known to be required for the accumulation of second-
ary, but not primary, endogenous siRNAs (34). Currently, it re-
mains unclear whether rsd-2 contributes to RDVI through a sim-
ilar mechanism. Here, we show that FR1gfp-deirved primary
siRNAs accumulated in rsd-2 with a pattern similar to that in rrf-1
or rde-1 single mutants, which are known to accumulate primary
viRNAs (Fig. 1E, 2A, and 3B). This finding suggests that, similar to
that in endogenous RNAi, rsd-2 enhances cell-autonomous anti-
viral silencing by contributing to the accumulation of secondary,
but not primary, viRNAs. This finding explained why rsd-2
mutants are resistant to low doses but sensitive to high doses of
dsRNAs (34). Presumably, when the trigger dsRNAs are present at
high concentrations, sufficient primary siRNAs will be produced
to trigger efficient RNAi in the absence of secondary siRNAs.
However, when the trigger dsRNAs are introduced at low levels,
efficient RNAi will require those dose-sensitive RNAi factors, such
as RSD-2, RDE-10, and RDE-11, which amplify RNAi by promot-
ing the production/accumulation of secondary siRNAs (34). No-
tably, the replication of both FHV and Orsay virus was further
enhanced in rsd-2 mutants compared to that in rrf-1 mutants,
suggesting that rsd-2 also contributes to the function of primary
viRNAs. RSD-2 contains 3 tandem domains of unknown function
at the N terminus. Functional characterization of these domains
may yield further insight into the mechanistic basis of RSD-2 in
RDVI.
Like that in plants, RNAi in C. elegans involves an intercellular
signal that is responsible for systemic spread of RNAi (32, 50, 51).
A recent study further suggested that long dsRNAs or their pro-
cessed intermediates are the physical carrier of this intercellular
signal (38). Consistent with this finding, systemic spreading of the
intercellular signal requires the transmembrane protein SID-1
that transports dsRNAs without a size preference and may facili-
tate the intercellular transportation of the silencing signal (33, 36,
47). Previously, it has been shown that SID-1 is dispensable for
RDVI triggered by artificial viruses, such as vesicular stomatitis
virus and FHV (4, 40). Currently, whether SID-1 contributes to
RDVI under natural conditions remains largely unknown. To ad-
dress this question, we compared Orsay virus infection between
wild-type N2 worms and sid-1 mutants and found that Orsay virus
infection was not further enhanced in the sid-1 mutants (Fig. 6).
Worm RDVI probably involves an intercellular silencing signal
that is transported through an SID-1-independent mechanism.
Consistent with this hypothesis, SID-1 was shown to be dispens-
able for the export of the mobile silencing signal in C. elegans (52).
Alternatively, SID-1, as a key component of systemic RNAi, may
be active in nonintestinal tissues, and as a result its role in systemic
FIG 7 Working model for rde-4-dependent and rde-4-independent antiviral
silencing in C. elegans. WAGO, worm-specific AGO (29). Here, we propose
that the processing of viral dsRNAs into primary viRNAs occurs in an rde-4-
dependent and rde-4-independent manner. drh-1 contributes to the rde-4-
dependent, but not rde-4-independent, antiviral silencing. We believe that
rsd-2 and rrf-1 contribute to both rde-4-dependent and rde-4-independent
antiviral silencing, while rde-1 plays a major function in the rde-4-dependent
antiviral silencing and a minor function in rde-4-independent antiviral silenc-
ing. We also believe that whereas the major function of rrf-1 is to direct the
synthesis of secondary viRNAs, rsd-2 contributes to the function of primary
viRNAs, thereby initiating the synthesis of secondary viRNAs. As proposed
previously, some WAGOs may direct the cleavage of cognate viral transcripts
using the secondary viRNAs as a sequence guide (29).
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RDVI cannot be identified using Orsay virus, which mainly targets
the intestine cells for replication (6). Moreover, probably due to
the lack of an RDVI suppression activity, Orsay virus is known to
be highly sensitive to RDVI (28). Thus, it is possible that the rep-
lication of Orsay virus in sid-1 mutants is suppressed by intracel-
lular antiviral silencing, making the intercellular antiviral silenc-
ing redundant in keeping this particular virus under control.
Unlike RDE-4, which plays an important role in the biogenesis
of endogenous siRNAs, DRH-1 appears to be a dedicated factor of
worm RDVI (5, 20). DRH-2 shares significant sequence homology
with DRH-1 but appears to negatively regulate worm RDVI (5).
These observations together raised the interesting question of
whether DRH-2 specifically targets and regulates the function of
DRH-1, thereby negatively regulating the rde-4-dependent RDVI.
Apparently, by addressing this question we will be able to find out
whether worms have evolved such a mechanism that would allow
for specific regulation of RDVI without affecting the normal cel-
lular function under unfavorable environments.
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